K. Christopher Farkas - 14 Mar 2024 Form 4 Insider Report for CURTISS WRIGHT CORP (CW)

Role
Vice President and CFO
Signature
Paul J. Ferdenzi by Power of Attorney from K. Christopher Farkas
Issuer symbol
CW
Transactions as of
14 Mar 2024
Net transactions value
-$271,285
Form type
4
Filing time
15 Mar 2024, 12:53:13 UTC
Previous filing
09 Feb 2024
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CW Common Stock Sale $657,078 -2,736 -23% $240.16 9,172 14 Mar 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CW Restricted Stock Unit Award $385,793 +1,601 +13% $240.97 13,475 14 Mar 2024 Common Stock 1,601 $0.000000 Direct F4, F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares were sold in compliance with the Company's share ownership guidelines whereby the executive may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
F2 Sale was made in accordance with a 10b5-1 plan maintained by Reporting Owner's financial advisor.
F3 Weighted average selling price of shares sold on March 14, 2024.
F4 No price on the date of issue, option having been granted as an employee benefit transaction.
F5 This is the date the Executive Compensation Committee of the Board of Directors approved the award.
F6 Number of shares is calculated by taking the amount of the Reporting Person's award and dividing that amount by the closing price of the Registrant's common stock on the date such award was earned.
F7 Price is based on the close price for the Registrant's common stock on March 14, 2024, the date the Executive Compensation Committee of the Board of Directors approved the awards.